Works by Mould-Quevedo, Joaquin
Results: 34
Editorial: Clinical, biological, and economic aspects of pediatric infections in Latin America.
- Published in:
- Frontiers in Public Health, 2024, p. 1, doi. 10.3389/fpubh.2024.1398071
- By:
- Publication type:
- Article
The cost-effectiveness of celecoxib versus non-steroidal anti-inflammatory drugs plus proton-pump inhibitors in the treatment of osteoarthritis in Saudi Arabia.
- Published in:
- Health Economics Review, 2015, v. 5, n. 1, p. 1, doi. 10.1186/s13561-015-0053-7
- By:
- Publication type:
- Article
Real-World Clinical and Economic Analysis of Cell-Derived Quadrivalent Influenza Vaccine Compared to Standard Egg-Derived Quadrivalent Influenza Vaccines During the 2019–2020 Influenza Season in the United States.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 1, p. 1, doi. 10.1093/ofid/ofab604
- By:
- Publication type:
- Article
Egresos hospitalarios por cáncer bucal en el IMSS (1991-2000).
- Published in:
- Revista Medica del IMSS, 2008, v. 46, n. 1, p. 101
- By:
- Publication type:
- Article
Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019–20 Influenza Season—A Retrospective Cohort Analysis.
- Published in:
- Vaccines, 2021, v. 9, n. 10, p. 1146, doi. 10.3390/vaccines9101146
- By:
- Publication type:
- Article
The Epidemiological and Economic Impact of a Cell-Based Quadrivalent Influenza Vaccine in Adults in the US: A Dynamic Modeling Approach.
- Published in:
- Vaccines, 2021, v. 9, n. 10, p. 1095, doi. 10.3390/vaccines9101095
- By:
- Publication type:
- Article
The Cost-Effectiveness of Expanding Vaccination with a Cell-Based Influenza Vaccine to Low Risk Adults Aged 50 to 64 Years in the United Kingdom.
- Published in:
- Vaccines, 2021, v. 9, n. 6, p. 598, doi. 10.3390/vaccines9060598
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Switching from Trivalent to Quadrivalent Seasonal Influenza Vaccine in Argentina.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 335, doi. 10.3390/vaccines9040335
- By:
- Publication type:
- Article
Clinical and Economic Outcomes Associated with Cell-Based Quadrivalent Influenza Vaccine vs. Standard-Dose Egg-Based Quadrivalent Influenza Vaccines during the 2018–19 Influenza Season in the United States.
- Published in:
- Vaccines, 2021, v. 9, n. 2, p. 80, doi. 10.3390/vaccines9020080
- By:
- Publication type:
- Article
Evaluating the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to High-Dose Trivalent and Other Egg-Based Influenza Vaccines among Older Adults in the US during the 2017–2018 Influenza Season.
- Published in:
- Vaccines, 2020, v. 8, n. 3, p. 446, doi. 10.3390/vaccines8030446
- By:
- Publication type:
- Article
Burden of disease from atrial fibrillation in adults from seven countries in Latin America.
- Published in:
- International Journal of General Medicine, 2014, v. 7, p. 441, doi. 10.2147/IJGM.S62819
- By:
- Publication type:
- Article
Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany.
- Published in:
- Journal of Medical Economics, 2021, v. 24, n. 1, p. 490, doi. 10.1080/13696998.2021.1908000
- By:
- Publication type:
- Article
Custo-efetividade da vacina contra influenza quadrivalente baseada em células comparada com a trivalente baseada em ovo do Programa Nacional de Imunizações brasileiro.
- Published in:
- JBES: Brazilian Journal of Health Economics / Jornal Brasileiro de Economia da Saúde, 2021, v. 13, n. 2, p. 136, doi. 10.21115/JBES.v13.n2.p136-44
- By:
- Publication type:
- Article
The economic rationale for cell-based influenza vaccines in children and adults: A review of cost-effectiveness analyses.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2351675
- By:
- Publication type:
- Article
Estimating the impact of influenza vaccination of low-risk 50–64-year-olds on acute and ICU hospital bed usage in an influenza season under endemic COVID-19 in the UK.
- Published in:
- Human Vaccines & Immunotherapeutics, 2023, v. 19, n. 1, p. 1, doi. 10.1080/21645515.2023.2187592
- By:
- Publication type:
- Article
The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom.
- Published in:
- Human Vaccines & Immunotherapeutics, 2021, v. 17, n. 11, p. 4603, doi. 10.1080/21645515.2021.1971017
- By:
- Publication type:
- Article
Absenteeism and Productivity Loss Due to Influenza or Influenza-like Illness in Adults in Europe and North America.
- Published in:
- Diseases, 2024, v. 12, n. 12, p. 331, doi. 10.3390/diseases12120331
- By:
- Publication type:
- Article
Análisis económico de dalteparina en la indicación cirugía de rodilla en el Instituto Mexicano del Seguro Social.
- Published in:
- Cirugía y Cirujanos, 2012, v. 80, n. 5, p. 411
- By:
- Publication type:
- Article
Direct medical costs of treating Mexican children under 2 years of age with respiratory syncytial virus.
- Published in:
- Boletín Médico del Hospital Infantil de México, 2012, v. 69, n. 2, p. 111
- By:
- Publication type:
- Article
Tratamiento antimicótico empírico de pacientes inmunocomprometidos con neutropenia y fiebre persistente con sospecha de aspergilosis sistémica: análisis de costo-efectividad en México.
- Published in:
- Boletín Médico del Hospital Infantil de México, 2009, v. 66, n. 3, p. 241
- By:
- Publication type:
- Article
A Clinical and Economic Comparison of Cell-Based Versus Recombinant Influenza Vaccines in Adults 18–64 Years in the United States.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1217, doi. 10.3390/vaccines12111217
- By:
- Publication type:
- Article
Modelling the Relative Vaccine Efficacy of ARCT-154, a Self-Amplifying mRNA COVID-19 Vaccine, versus BNT162b2 Using Immunogenicity Data.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1161, doi. 10.3390/vaccines12101161
- By:
- Publication type:
- Article
Cost-Effectiveness of Adjuvanted Quadrivalent Influenza Vaccine for Adults over 65 in France.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 574, doi. 10.3390/vaccines12060574
- By:
- Publication type:
- Article
Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Children: A Narrative Review.
- Published in:
- Vaccines, 2023, v. 11, n. 10, p. 1594, doi. 10.3390/vaccines11101594
- By:
- Publication type:
- Article
The Impact of Adjuvanted Influenza Vaccine on Disease Severity in the US: A Stochastic Model.
- Published in:
- Vaccines, 2023, v. 11, n. 10, p. 1525, doi. 10.3390/vaccines11101525
- By:
- Publication type:
- Article
Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion.
- Published in:
- Vaccines, 2023, v. 11, n. 6, p. 1089, doi. 10.3390/vaccines11061089
- By:
- Publication type:
- Article
Cost-Effectiveness of the Use of Adjuvanted Quadrivalent Seasonal Influenza Vaccine in Older Adults in Ireland.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 933, doi. 10.3390/vaccines11050933
- By:
- Publication type:
- Article
Cost-Effectiveness of Vaccination of Older Adults with an MF59 ® -Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 753, doi. 10.3390/vaccines11040753
- By:
- Publication type:
- Article
Estimating the Impact of Influenza Vaccination on Acute and ICU Hospital Bed Usage in an Influenza Season under Endemic COVID-19 in the US.
- Published in:
- Vaccines, 2022, v. 10, n. 11, p. 1908, doi. 10.3390/vaccines10111908
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Cell Versus Egg-Based Seasonal Influenza Vaccination in Children and Adults in Argentina.
- Published in:
- Vaccines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/vaccines10101627
- By:
- Publication type:
- Article
The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany.
- Published in:
- Vaccines, 2022, v. 10, n. 9, p. 1386, doi. 10.3390/vaccines10091386
- By:
- Publication type:
- Article
An Economic Comparison of Influenza Vaccines Recommended for Use in Eligible Adults under 65 Years in the United Kingdom.
- Published in:
- Vaccines, 2022, v. 10, n. 4, p. N.PAG, doi. 10.3390/vaccines10040599
- By:
- Publication type:
- Article
The hospital appropriateness evaluation protocol in elderly patients: a technique to evaluate admission and hospital stay.
- Published in:
- Scandinavian Journal of Caring Sciences, 2008, v. 22, n. 2, p. 306, doi. 10.1111/j.1471-6712.2007.00528.x
- By:
- Publication type:
- Article